Tracing mitochondrial marks of neuronal aging in iPSCs-derived neurons and directly converted neurons
This study aims to determine if neurons derived from induced pluripotent stem cells (iPSCsNs) and directly converted neurons (iNs) from the same source cells exhibit changes in mitochondrial properties related to aging. This research addresses the uncertainty around whether aged iPSCsNs retain aging-associated mitochondrial impairments upon transitioning through pluripotency while direct conversion maintains these impairments. We observe that both aged models exhibit characteristics of aging, such as decreased ATP, mitochondrial membrane potential, respiration, NAD<sup>+</sup>/NADH ratio, and increased radicals and mitochondrial mass. In addition, both neuronal models show a fragmented mitochondrial network. However, aged iPSCsNs do not exhibit a metabolic shift towards glycolysis, unlike aged iNs. Furthermore, mRNA expression differed significantly between aged iPSCsNs and aged iNs. The study concludes that aged iPSCsNs may differ in transcriptomics and the aging-associated glycolytic shift but can be a valuable tool for studying specific feature of mitochondrial neuronal aging in vitro alongside aged iNs.
Authors
- Nimmy Varghese (ORCID: https://orcid.org/0000-0001-8598-0535)
- M. Zameel Cader (ORCID: https://orcid.org/0000-0002-6952-406X)
- Amandine Grimm (ORCID: https://orcid.org/0000-0003-3323-1756)
- Anne Eckert (ORCID: https://orcid.org/0000-0002-9341-3669)
- Leonora Szabo (ORCID: https://orcid.org/0000-0001-5117-3778)
- Imane Lejri (ORCID: https://orcid.org/0000-0002-5379-5412)
Institutions
- University of Basel (CH)
- University of Oxford (GB)
- Max Planck Florida Institute for Neuroscience (US)
- Universitäre Psychiatrische Kliniken Basel (CH)
Publication Details
- Journal
- Communications Biology
- Published
- 2025-05-09
- DOI
- https://doi.org/10.1038/s42003-025-08152-2
- Citations
- 1
- Primary Topic
- Pluripotent Stem Cells Research
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- National Science Foundation
- Novartis Foundation
- European Commission
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Fondation pour la Recherche Médicale